We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Grants Authorization Allowing Research Institute to Study Psychedelic Use by Therapists

This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.

Read More

Synthetic Psychedelic Reduces Stress in Mice, Study Finds

Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.

Read More

The Ins and Outs of Psychedelic-Assisted Psychotherapy

Analytical Cannabis' sister publication, Technology Networks, explores the benefits of psychedelic-assisted therapy.

Read More

Drug-finding Tool Identifies Psychedelic-like Drug That Is Hallucination-free

A new technology developed by researchers at the University of California Davis promises to fast-track the development of compounds that could exploit psychedelics’ therapeutic action without hallucinogenic side effects.

Read More

Psilocybin Compared to Antidepressant in Breakthrough Trial

A new trial has directly compared the antidepressant effects of psilocybin with a more classical antidepressant, and found that the two are matched in their mood-altering potential.

Read More

Could a Chemical Flip Produce a More Effective Ketamine-based Antidepressant?

Drug developers say that R-ketamine could potentially deliver a more targeted action with fewer side effects than its more popular chemical twin.

Read More

Could the “Spirit Molecule” DMT Assist in Stroke Recovery?

N,N-dimethyltryptamine (DMT) is a psychedelic compound under investigation for a range of therapeutic uses. One avenue of research is being pursued by Algernon Pharmaceuticals, who are investigating whether sub-hallucinogenic DMT doses could help to protect and repair the brain in the hours after a stroke.

Read More

The Current State of Psychedelic Research

Scientific research groups have only begun investigating the properties of psychedelic compounds relatively recently. But what have they uncovered so far?

Read More

A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests

People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.

Read More

 
Advertisement